• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Effects of long COVID on healthcare utilization

tetano

Editor, Senior Moderator
PLoS One


. 2025 Jul 23;20(7):e0327218.
doi: 10.1371/journal.pone.0327218. eCollection 2025. Effects of long COVID on healthcare utilization

Michael Gottlieb[SUP] 1 [/SUP], Erica S Spatz[SUP] 2 3 4 [/SUP], Huihui Yu[SUP] 2 4 [/SUP], Imtiaz Ebna Mannan[SUP] 4 [/SUP], Michelle Santangelo[SUP] 1 [/SUP], Caitlin Malicki[SUP] 5 [/SUP], Nicole L Gentile[SUP] 6 7 [/SUP], Rachel E Geyer[SUP] 6 [/SUP], Alex Charlton[SUP] 8 [/SUP], Jonathan W Dyal[SUP] 9 [/SUP], Joann G Elmore[SUP] 10 [/SUP], Kristyn Gatling[SUP] 11 [/SUP], Mandy J Hill[SUP] 12 [/SUP], Juan Carlos C Montoy[SUP] 13 [/SUP], Kelli N O'Laughlin[SUP] 14 [/SUP], Kristin L Rising[SUP] 8 15 [/SUP], Sharon Saydah[SUP] 16 [/SUP], Kari A Stephens[SUP] 6 17 [/SUP], Ralph C Wang[SUP] 13 [/SUP], Lauren E Wisk[SUP] 10 [/SUP], Arjun K Venkatesh[SUP] 4 5 [/SUP], Robert A Weinstein[SUP] 11 18 [/SUP]; Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group



Affiliations
Abstract

Background: While most research on Long COVID (LC) has focused on symptoms and quality of life, there remains a critical need to better understand the effect of LC on resource utilization. This study sought to determine the type and amount of healthcare utilization among participants with versus without LC.
Methods: This was a secondary analysis of a prospective, longitudinal, multicenter U.S. study of adult participants with symptomatic COVID-19, confirmed with testing, who completed 3-month post-infection surveys and had electronic health record data for at least 180 days pre- and post-index testing. We excluded participants with any COVID-19 infections within the 6 months following enrollment. Consistent with prior work, LC was defined as ≥3 post-infectious symptoms at 3 months, while those with <3 symptoms were categorized as not having LC. Our primary outcome was to compare the change in visit types between pre- and post-index testing (hospitalization, emergency department visit, office visit, procedure, telehealth, and other). As secondary outcomes, we assessed differences in visit complexity using the summative length of each encounter for each category as a measure of total healthcare usage.
Results: A total of 847 participants met inclusion criteria (179 LC, 668 non-LC). When compared with the pre-index period, there was an overall increase in visit numbers of all six visit categories during the post-index period for all groups, most pronounced in office and telehealth visits. When compared with the non-LC group, the LC group was less likely to have ED visits (OR: 0.1; 95% CI 0.0-0.5). However, among those with LC who had at least one hospitalization, they were more likely to have additional hospitalizations (OR: 2.6; 95% CI 1.5-4.6). Visit length for office visits and hospitalization in the LC group was increased when compared with the non-LC group, though this diminished after adjustment for patient baseline characteristics.
Conclusions: All participants who were infected with SARS-CoV-2 had a marked increase in healthcare utilization during the subsequent 180 days. The LC group had significantly higher rates of additional hospitalization compared with those without LC, which may help to inform healthcare resource planning.


 
Back
Top Bottom